Search Results for ''

published presentations and documents on DocSlides.

MULTIPLE SCLEROSIS DISEASE MANAGEMENT
MULTIPLE SCLEROSIS DISEASE MANAGEMENT
by stefany-barnette
Introduction of Case Study. In this case the pers...
Using Non-targeted Therapies in Targeted Lung Cancer Popula
Using Non-targeted Therapies in Targeted Lung Cancer Popula
by ellena-manuel
Nathan Pennell, M.D., Ph.D.. September 6, 2014. O...
Targeted Therapies Against Lymphocyte Signaling Pathways in
Targeted Therapies Against Lymphocyte Signaling Pathways in
by min-jolicoeur
Stuart S. Winter, MD. Pediatric Hematology/Oncolo...
Advances in Insulin Therapies for
Advances in Insulin Therapies for
by natalia-silvester
the Treatment of T1DM and T2DM. Lawrence Blonde,...
Terapia
Terapia
by min-jolicoeur
targeted. : . limiti e successi nelle metastasi ...
New Therapies for Metastatic Breast Cancer
New Therapies for Metastatic Breast Cancer
by alexa-scheidler
Sigrun Hallmeyer, MD. Oncology Specialists, SC. D...
Talking to Patients About Overactive Bladder:
Talking to Patients About Overactive Bladder:
by conchita-marotz
. What Every Provider Should Know. Program Goals...
Solent NHS Trust
Solent NHS Trust
by karlyn-bohler
Alex Whitfield. Chief Operating Officer. Services...
Pain Attenuation with  Integrative
Pain Attenuation with Integrative
by DynamicDiva
Therapy in . Post . Mastectomy Patients. Sharp Mem...
ICER’s Experience With Treatment-Process Utilities for Gene Therapies
ICER’s Experience With Treatment-Process Utilities for Gene Therapies
by caiden560
Melanie D. Whittington, PhD. Director of Health Ec...
Is More or Less Better? Reviewing Therapies in Hematologic Cancers
Is More or Less Better? Reviewing Therapies in Hematologic Cancers
by ash
. Press Briefing. Moderator: Mikkael Sekeres. , MD...
Cancer Survivorship and Rehabilitation
Cancer Survivorship and Rehabilitation
by abigail
Jennifer M. Jones, PhD. Director, Cancer Rehabilit...
Underutilized Drug Therapies in Pain Management
Underutilized Drug Therapies in Pain Management
by joyce
Nathan Bryant, PharmD. Pain Management Pharmacist....
Emerging therapies for alopecia areata
Emerging therapies for alopecia areata
by jasmine
Antonella Tosti, MD. Miller School of Medicine, Un...
Scott Gottlieb MD
Scott Gottlieb MD
by eliza
1 October 10, 2018 Commissioner Food and Drug Admi...
Understanding the Convergence ofComplementary Alternative  Clearly
Understanding the Convergence ofComplementary Alternative Clearly
by mary
1 The appeal of these non-conventional therapies i...
Executive Summary Complex medical diet therapies are often hard to execute, follow and maintain by
Executive Summary Complex medical diet therapies are often hard to execute, follow and maintain by
by RainbowGlow
T. he . power of food . helps heal our patients, b...
Evolving Therapies for Elderly Patients with Blood Cancers
Evolving Therapies for Elderly Patients with Blood Cancers
by grewhypo
Andrew Artz, MD, MS. Associate Professor of Medici...
Fabry Disease: new therapies in 2019
Fabry Disease: new therapies in 2019
by dorothy
Dr. Michael L. West. Division of Nephrology. Depar...
Cancer Trials 30 years in the making
Cancer Trials 30 years in the making
by dorothy
Professor John . Simes. Director, NHMRC Clinical T...
Virtual Patients for Digital Trials of Diabetes Therapies in the Age of AI
Virtual Patients for Digital Trials of Diabetes Therapies in the Age of AI
by amelia
Mudassir Rashid. Illinois Institute of Technology....
A phase 2 study with  cabozantinib
A phase 2 study with cabozantinib
by unita
in collecting duct carcinoma (Bellini). Giuseppe P...
Therapies for Clinically Localized Prostate Cancer
Therapies for Clinically Localized Prostate Cancer
by fauna
Background A National Institutes of Health NIH pan...
CHI-California Healthcare Institute is a non-profit public policy rese
CHI-California Healthcare Institute is a non-profit public policy rese
by bigboybikers
biomedical R&D industry. CHI represents more than ...
Targeted therapies against Acute Myeloid Leukemia
Targeted therapies against Acute Myeloid Leukemia
by triclin
Hiba . El Hajj, Ph.D.. Assistant Professor, . Depa...
Positive Impacts of Developing Novel Endpoints
Positive Impacts of Developing Novel Endpoints
by ryotheasy
Generated by Mobile Technology for . Use in Clinic...